The insider cluster is too small to drive a trading decision. Monitor for any follow-on insider buying from C-suite or larger 10% owner purchases. The recent refinancing is the more significant catalyst; watch for Q3 earnings to assess covenant feasibility under the new OrbiMed loan.
Price Chart
Executive Summary
A small insider cluster at Oncology Institute (TOI) shows a 10% owner buying $88K in shares while the CMO sold $116K after exercising derivatives. The total $203K in trades represents just 0.036% of TOI's $566M market cap, making the activity trivial and likely routine. The cluster follows a major refinancing 8-K (July 7) that eliminated convertible debt overhang, but the insider moves do not provide a material signal.
Key Financial Metrics
Key Facts
- CMO Podnos Yale sold $116K in open-market sales after exercising derivatives at low strike prices (routine liquidity event).
- 10% owner Chernett Jorey bought $88K worth of shares on July 10, a modest positive signal.
- Total cluster value of $203K is only 0.036% of TOI's $566M market cap, well below the 0.1% materiality threshold.
- Cluster occurred 9 days after TOI's $75M OrbiMed term loan refinancing (8-K filed July 7), which removed near-term convertible debt overhang.
Financial Impact
Trivial, $203K in insider trades vs. $566M market cap (0.036%). No material financial impact.
Risk Factors
- The CMO's sale, while routine, could signal lack of conviction if followed by additional C-suite sales.
- The $700M minimum net revenue covenant on the OrbiMed loan starting Q4 2027 creates long-term performance pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TOI-1784250065127 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 9w ago | 8-K | $6.09 $6.32 | ▲ +3.78% | ▲ +3.86% | $6.34 (+4.11%) |
Aug 24, 2026 10w ago | Insider Cluster | $6.30 $6.82 | ▲ +8.25% | ▲ +8.01% | $6.34 (+0.63%) |
Aug 17, 2026 11w ago | Insider Buy | $6.31 $6.37 | ▲ +0.95% | ▲ +2.93% | $6.34 (+0.48%) |
Jul 22, 2026 14w ago | Insider Buy | $5.29 | awaiting T+20 | awaiting T+20 | $6.34 (+19.85%) |
Jul 22, 2026 14w ago | Insider Cluster | $5.29 | awaiting T+20 | awaiting T+20 | $6.34 (+19.85%) |
Jul 16, 2026 15w ago | Insider Cluster | $5.35 | awaiting T+20 | awaiting T+20 | $6.34 (+18.50%) |
Jul 13, 2026 16w ago | Insider Buy | $6.25 | awaiting T+20 | awaiting T+20 | $6.34 (+1.44%) |
Jun 9, 2026 21w ago | Insider Cluster | $4.68 $5.85 | ▲ +25.00% | ▲ +21.38% | $6.34 (+35.47%) |
Apr 9, 2026 29w ago | Insider Cluster | $3.11 $3.80 | ▲ +22.19% | ▲ +14.62% | $6.34 (+103.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers